Date: July 20, 2019
Location: Hotel Camino Real Polanco, Mexico City, Mexico
Andrea Howard, MD, MS, director of ICAP’s clinical and training unit, and Peter Preko, MBChB, MPH, CQUIN program director, will present at the IAS TB/HIV 2019 Symposium as part of IAS 2019 in Mexico City.
Dr. Howard’s presentation, “TB prevention in HIV-associated TB: opportunities and challenges,” will take place from 11:10 – 11:25 a.m. during “Session 3: Opportunities to scale up TB preventive treatment,” co-chaired by Vanessa Rouzier (GHESKIO, Haiti) and Kate Thomson (The Global Fund, Switzerland).
Dr. Preko’s presentation, “Use of differentiated service delivery approaches for TB prevention and care,” will take place from 1:50 – 2:05 p.m. during “Session 4: Field perspectives in scaling up TB preventive treatment among people living with HIV,” co-chaired by Sevim Ahmedov (USAID, USA) and Adeeba Kamarulzaman (University of Malaya, Malaysia).
Full IAS TB/HIV symposium schedule
Click here for ICAP’s IAS 2019 conference schedule
Session 3: Opportunities to scale up TB preventive treatment
11:05 a.m. – 12:15 p.m.
Vanessa Rouzier (GHESKIO, Haiti)
Kate Thomson (The Global Fund, Switzerland)
- 11:05 – 11:10: Overview of the session
Co-chairs Vanessa Rouzier (GHESKIO, Haiti) and Kate Thomson (The Global Fund, Switzerland)
- 11:10 – 11:25: TB prevention in HIV-associated TB: Opportunities and challenges
Andrea Howard (ICAP at Columbia University, USA)
- 11:25 – 11:40: TB prevention in pregnant women and children
Jyoti Mathad (Weill Cornell Medical College, USA)
- 11:40 – 11:55: Prevention of DR-TB
Gavin Churchyard (The Aurum Institute, South Africa)
- 11:55 – 12:05: Operationalizing tools to scale up TB preventive treatment
Sean Cavanaugh (CDC, USA)
- 12:05 – 12:20: Scaling TB preventive treatment: The experience of South Africa
Hala Almossawi (USAID, USA)
- 12:20 – 12:30: Q&A panel
Session 4: Field perspectives in scaling up TB preventive treatment among people living with HIV
1:30 p.m. – 3:05 p.m.
Sevim Ahmedov (USAID, USA)
Adeeba Kamarulzaman (University of Malaya, Malaysia)
- 13:30 – 13:35: Overview of the session
Co-chairs Sevim Ahmedov (USAID, USA) and Adeeba Kamarulzaman (University of Malaya, Malaysia)
- 13:35 – 13:50: Maximizing engagement in care and adherence to TB preventive treatment
Lucy Connell (USAID, South Africa)
- 13:50 – 14:05: Use of differentiated service delivery approaches for TB prevention and care
Peter Preko (ICAP at Columbia University, Eswatini)
- 14:05 – 14:20: The right to TB preventive treatment: Considerations for access and equity for key populations
Harry Hausler (TB HIV Care, South Africa)
- 14:20 – 14:35: Perspectives from the community: Demand creation and promotion of TB preventive treatment
Esnath Manhiri (Zimbabwe National Network of People Living with HIV)
- 14:35 – 14:50: Lessons learnt from scaling up TB prevention programmes from a national HIV programme
Denise Arakaki (TB Programme Director/Deputy HIV Programme Director Brazil)
- 14:50 – 15:05: Q&A panel
TB/HIV 2019 symposium
A new era in TB prevention: Implications for people living with HIV
The International AIDS Society HIV Co-Infections and Co-Morbidities initiative is pleased to announce the TB/HIV 2019 symposium, “A new era in TB prevention: Implications for people living with HIV”, as an event entirely devoted to basic and translational research and implementation at the intersection of TB and HIV, and focused on TB prevention.
Saturday, July 20, 2019
8:00 a.m. – 5:30 p.m.
Hotel Camino Real Polanco
Full IAS TB/HIV symposium schedule
More information is available on the IAS website
The TB/HIV 2019 symposium will be convened just prior to IAS 2019 and will be co-hosted by the International AIDS Society (IAS) in collaboration with the Stop TB Partnership and the United States Agency for International Development (USAID).
This symposium will represent a unique opportunity to bring together a diversity of scientific, programmatic and community interests from of both the HIV and TB fields to share current knowledge on science of latent TB infection, as well as present and future opportunities and challenges in HIV-associated TB prevention. Sessions will explore the latent TB infection, from the biology and immunology perspective, current and future treatment options and the policy and implementation perspectives to decrease the burden of TB in HIV programs, including programmatic approaches through primary health care and differentiated service delivery as crucial opportunities to reach global TB an HIV goals worldwide. Additional focus will also be given to the current and future developments of TB vaccines and the relevance and implications for high burden HIV settings. A final call for action will aim to define and galvanize global and national efforts to increase coverage and attention to reach the new TB prevention goals globally.
The programme will display a mixture of formats, including focused thematic keynotes, a panel discussion, as well as an abstract driven poster exhibition, which will help drive interest from people working in HIV and the TB fields. In addition, the views from the civil society perspectives will allow grounding the topics in real-life experiences. The symposium will emphasize the action that the HIV and TB communities need to take jointly to reach global targets.
The TB/HIV 2019 symposium: A new era in TB prevention: Implications for People living with HIV will cover contemporary topics related to:
- Tackling latent TB towards reaching the TB and HIV global goals
- Science of TB latency, research and innovation in TB prevention: implications for people living with HIV. New TB prevention treatments, development of TB vaccines
- Opportunities to scale up TB preventive treatment, including in HIV-associated TB, children and pregnant women and Drug-Resistant TB
- Field perspectives in scaling up TB preventive treatment among people living with HIV: programmatic bottleneck, adherence to treatment, community demand creation, lessons learnt from programs in the scale-up
The meeting will be co-chaired by Dr. Alfredo Ponce de León (National Institute Salvador Zubirán in Mexico) and Dr. Beatriz Grinsztejn (Instituto National de Infectologia Evando Chagas-Fiocruz, Brazil and IAS Governing Council member).